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Prevalence of celiac disease (CD) in children is reported to be approximately 1% in both India and western world  [1-4]. Recent increase in prevalence of CD has been 
reported, which may be attributed to growing awareness among 
parents and clinicians, ease and accessibility to serological testing 
and endoscopic facilities [5-7]. Besides common gastrointestinal 
symptoms, failure to thrive, short stature and refractory anemia 
are the common atypical manifestations reported in children. 
Till date, only few Indian studies have reported clinical and 
laboratory profile in children with CD [8-12]. We evaluated 
clinical and laboratory profile of North Indian children with CD 
and also correlated duodenal biopsy Marsh stage and IgA tissue 
transglutaminase antibody (tTG) titers with serum hemoglobin, 
serum iron levels, and severity of anemia.
METHODS
This retrospective study was done in pediatric gastroenterology 
clinic of a tertiary care center in North India. Ethical clearance 
from the Ethical Committee of the institute was taken. Hospital 
records of the children aged 0-18 years, who attended the pediatric 
gastroenterology clinic between July 2014 and December 2015, 
were screened for those with presumptive diagnosis of CD. The 
diagnosis of CD was made as per the diagnostic criteria by the 
World Gastroenterology Organization 2012, i.e., symptomatic 
children or asymptomatic with positive family history, with 
positive serology (IgA tTG >10 U/ml) and biopsy suggestive of 
villous atrophy (Marsh staging 3) [13]. Records of 60 children 
with presumptive CD were reviewed and analyzed. Of these, 
6 patients were excluded due to incomplete records (2) or not 
meeting the diagnostic criteria (4). 54 children were finally 
enrolled.
The following data were recorded age, sex, age of onset, 
duration of disease, gastrointestinal symptoms (chronic diarrhea, 
vomiting, pain abdomen, abdomen distention, anorexia, and 
constipation) and non-gastrointestinal manifestations (failure to 
thrive, short stature, anemia, features of rickets, other vitamin 
deficiencies, and skin lesions) and anthropometry (Z scores 
for height for age, weight for height [<5 year] and body mass 
index [BMI] [>5 years]). WHO growth charts were used as 
standard reference for anthropometry [14]. Details of laboratory 
parameters (hemoglobin, severity of anemia, serum iron levels, 
serum calcium, serum glutamic oxaloacetic transaminase (SGOT) 
and serum glutamic pyruvic transaminase (SGPT), IgA levels, IgA 
anti tTG antibodies, and duodenal biopsy findings (Marsh staging) 
were also noted. The cutoff for various laboratory parameters 
mentioned were taken from standard references used in pediatric 
population [15,16]. A note was also made of associated disorders.
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Statistical analysis was performed by the Stata version 14.1 
software. Quantitative variables were represented by means and 
qualitative variables by percentages. Correlation of tTG levels and 
duodenal biopsy (Marsh staging) with serum hemoglobin, serum 
iron, severity of anemia, and iron deficiency was determined 
using regression analysis. p≤0.05 was considered as significant.
RESULTS
A total of 54 children were diagnosed with CD between July 2014 
and December 2015. Table 1 shows the clinical and laboratory 
details of the enrolled children. The mean age of enrolled 
children was 8±3.6 years (range: 20 months-17 years), and most 
children were >5 years (75.8%) with a female predominance 
(Male:Female ratio - 2:3). Average age of onset of symptoms 
was 4.7±2.5 years (range: 8 months - 11 year). 81% (44/54) of 
children had onset of symptoms after 2 years with earliest child 
presenting at 8 months. Most children (52/54) presented with 
gastrointestinal symptoms except 2 patients, who presented with 
failure to thrive and anorexia. Chronic diarrhea (70.3%), pain 
abdomen (62.9%), and abdomen distention (53.7%) were the 
most common manifestations. Other presenting features included 
vomiting, constipation, weight loss, rectal prolapse, anorexia, and 
not gaining weight. Family history of CD was present in 16.7% 
of children (siblings - 8, father - 1). Anthropometry showed 
wasting in 38.4% (5/13) and undernourishment (BMI score <2z 
score) in 41.4% (17/41) of children ≤5 years of age and >5 years 
age, respectively. Stunting was present in half (46.3%) of the 
children (height/age <2z score) of which 18.5% were severely 
stunted (<3z score). On clinical examination, main manifestations 
were pallor (62.9%) and rickets (22%). Other findings included 
edema, ascites, dermatitis, and oral ulcers.
Laboratory Parameters
Mean hemoglobin was 8.11±2.32 g/dl (range 3.1-12.8 g/dl) with 
anemia in 90.7% cases (48.1% severe anemia). Iron deficiency 
anemia (serum iron <60 mcg/dl) was seen in 77.8% 
children. Mean serum iron levels were 37.25±23.14 µg/dL 
(range 5-97 µg/dL). Hypocalcemia (48%) and raised liver 
enzymes (SGOT, SGPT) (45%) were commonly seen (Table 1). 
Other associated systemic disorders were hypothyroidism (n=2), 
diabetes mellitus type 1 (n=1), and autoimmune hepatitis 
(n=1). Most of the children enrolled in the study had tTG IgA 
levels between 100 and 500 U/ml (85%) and duodenal biopsy 
conclusive of 3b Marsh staging (52%). Most of the children in 
the enrolled group 39/54 (72.2%) were on gluten free diet for the 
last 6 months.
Children were grouped according to Biopsy Marsh stages. 
Correlation analysis between Marsh staging and serum tTG with 
mean hemoglobin, mean serum iron, presence of iron deficiency, 
and severity of anemia was done (Table 2). The results showed 
that mean serum iron and mean hemoglobin levels decreased with 
increasing serum tTG levels and biopsy staging, but the correlation 
was not significant (p>0.05). However, on logistic regression 
Table 1: Clinical and laboratory details of enrolled children with 
celiac disease
Parameter Number of 
children
Percentage of 
children
Age (years)
≤2 2 3.7
>2‑≤5 11 20.3
>5‑≤10 26 48.2
>10 15 27.8
Sex
Males 21
Females 33
Age at onset of symptoms (year)
≤2 10 18.5
>2‑≤5 23 42.6
>5 21 38.9
Symptoms and signs
Chronic diarrhea 38 70.3
Vomiting 21 38.8
Abdomen distention 29 53.7
Pain abdomen 34 62.9
Rectal prolapse 3 5.5
Constipation 8 14.8
Anorexia 20 37.0
Not gaining weight 25 46.2
Oral ulcer 5 9.2
Pallor 34 62.9
Rickets 12 22
Others (edema, ascites, skin 
changes)
8 14.8
<5 year: Wasting, severe wasting 5/13, 2/13 38.4, 15.3
>5 year: BMI<2 SD 17/41 41.4
Stunting (severe stunting) 25/54 (10/54) 46.3 (18.5)
Anemia 49/54 90.7
Severe/moderate/mild 26/16/7 48.1/29.6/12.9
Iron deficiency 42/54 77.8
Hypocalcemia (<8.8 mg/dl) 24/50 48
Raised transaminases 24/54 45
tTG values (U/ml)
>10-<100 7 12.9
100-<200 24 44.4
≥200 23 41.5
Duodenal biopsy (Marsh staging)
3A 10 18.5
3B 33 61.1
3C 11 20.3
BMI: Body mass index, SD: Standard deviation
analysis, the decrease in hemoglobin levels from Marsh stage 3A 
to 3C was statistically significant (p=0.036) (Table 2).
There was no significant correlation between iron deficiency 
and Marsh staging (odds ratio of 3A vs. 3B=2.47, p=0.241 and 
3A vs. 3C=6.66, p=0.123). Furthermore, no significant correlation 
was found between iron deficiency and serum tTG levels (Odds 
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ratio of 3A vs. 3B=2.25, p=0.366 and 3A vs. 3C=5, p=0.102). 
The percentage of children with severe anemia increased with 
increase in Marsh stage. However, correlation of severity of 
anemia with Marsh staging or with serum tTG levels was not 
significant (p=0.641 and p=0.484, respectively) (Table 3). There 
was no significant correlation between serum tTG levels with 
Marsh staging (p=0.19).
DISCUSSION
In this study of 54 children with CD, the mean age of children 
was 8±3.6 years with female predominance and onset of 
symptoms after 2 years in 80% children. The common symptoms 
were chronic diarrhea (70.3%), pain abdomen (62.9%), and 
abdomen distention (53.7%). Stunting (46.3%), wasting (38.4%), 
anemia (85.1%), rickets (22%), and raised liver enzymes (45%) 
were commonly observed. Other associated disorders found 
were hypothyroidism (n=2), diabetes mellitus type 1 (n=1), and 
autoimmune hepatitis (n=1).
The mean age of enrolled children in the previous studies ranged 
from 6 to 8 years and was similar to our study (8 years) [9-11]. 
The age of onset of symptoms in our study 4.7±2.56 years was 
only slightly higher as compared to Poddar et al. (3.2±1.9 years) 
and Rawal et al. (3.4±2.6 years) [10,11]. The duration of 
symptoms before diagnosis was much lower in our study group 
(2.68±2.26 years) than Patwari et al. (5.2±3 years), indicating 
early diagnosis, which could be because of better diagnostic 
techniques and higher suspicion of disease in recent years [9]. 
Chronic diarrhea still remains the most common presentation of 
CD (70.5% in our study vs. 54-94% in past reports). As compared 
to previous Indian studies higher percentage of children in our 
study had abdomen pain, vomiting, and constipation [8-11]. This 
may be due to tendency of clinicians to evaluate only cases of 
diarrhea for CD in past.
We found only 2 patients (2/54) with atypical CD, similar 
to Mohindra et al. [12]. Few western studies have shown higher 
number of atypical CD [6,17-20] compared to Indian studies 
which might be because of under diagnosis of cases with non-
gastrointesinal symptoms in our country. Incidence of pallor 
and short stature was similar to past studies. However, we found 
higher number of rickets patients 12/54 (22%) in our study. 
Increased incidence of rickets in CD may be associated with 
decreased duodenal absorption of calcium (absorbed mainly from 
duodenum) and fat malabsorption which affects serum vitamin D 
levels [21]. The increase in incidence of rickets in our study may 
be attributed to growing subclinical vitamin D deficiency in 
general population.
Among laboratory parameters mean hemoglobin in 
our study (8.1 mg/dl) was comparable to previous studies 
(range 7.7-8.8 mg/dl) [9,11]. Similar to our study high incidence 
of anemia (90.7%) was also documented by Rawal et al. (100%), 
Poddar et al. (84%), and Thappa et al. (100%) [8,10,11]. 
Mean serum iron levels in our study were 37.25 µg/dl, similar 
to those reported by Sherwani et al. and Qari of 29.2 µg/dl 
and 38.2 µg/dl, respectively [22,23]. Pathophysiology of anemia in 
CD is multifactorial including impaired duodenal iron absorption, 
occult gastrointestinal blood loss, intravascular hemolysis due to 
other autoimmune disorder and co-existent chronic inflammatory 
disease, anemia of chronic disease, low erythropoietin for degree 
of anemia, etc., in CD patients. Iron deficiency anemia in CD 
patients is refractory to iron therapy alone and responds after 
gluten free diet [24-26]. Inverse correlation of serum iron and 
serum hemoglobin with duodenal biopsy Marsh stage and serum 
tTG levels have been previously reported by Kalhan et al. [27]. He 
found significant linear association in both percentage of patients 
with iron deficiency anemia and mean baseline hemoglobin 
levels from Marsh staging of duodenal biopsy Stage 1 and 2 to 
3C and 4 (p<0.001) [27]. In our study, we enrolled children with 
biopsy Stage 3 only. This may be the possible cause of absence of 
any significant correlation with increasing severity of duodenal 
biopsy stages. However, the correlation of 3A vs. 3C biopsy 
stage and hemoglobin levels was significant in our study. Liver 
Table 2: Logistic regression analysis for correlation between biopsy staging and tTG levels versus mean serum hemoglobin and mean serum 
iron serum levels
Biopsy staging (Marsh) Hemoglobin 
mean±SD
95% CI Co-efficient p value Iron levels 
mean±SD
95% CI Co-efficient p value
3A 9.38±1.7 7.93, 10.82 # 46±28 31.34, 60.65 #
3B 8.01±2.4 −3.00, 0.28 −1.36 0.10 36.6±23 −26.03, 7.42 −15 0.27
3C 7.24±2.2 −4.12, 0.14 −2.13 0.04* 31±17 −35.24, 0.52 −9.3 0.14
tTG levels
10-100 8.5±2.9 6.7, 10.3 # 42.7±27 25.11, 60.32 #
>100-200 8.23±2.1 −2.3, 1.7 −0.27 0.8 40.1±25.8 −30.2, 9.9 −2.54 0.32
>200 7.86±2.4 −2.7, 1.4 −0.63 0.54 32.5±18.8 −22.55, 17.5 −10.15 0.8
#3A and serum tTG levels 10-100 were taken as constant, *Correlation of hemoglobin levels in 3A v/s 3C is significant. CI: Confidence interval, SD: Standard deviation
Table 3: Distribution of percentage of children in each category of 
anemia according to marsh staging and serum tTG titers
Category of 
anemia
Biopsy 
stage (MARSH)
Serum tTG titers (U/ml)
3A 3B 3C 10-100 >100-200 >200
No anemia 20 9.09 0 28.57 4.17 8.7
Mild anemia 10 15.15 9.09 0 16.67 13.04
Moderate 
anemia
40 27.27 27.27 14.29 33.33 30.43
Severe 
anemia
30 48.48 63.64 57.14 45.83 47.83
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enzymes were slightly raised in our CD children, which was also 
found, by Rawal et al. and Poddar et al. [10,11]. Marsh stage 3B 
was found to be the most common (60.4%) finding on duodenal 
biopsy of these patients as found by Rawal et al. (64.2%) [11].
The main limitation of our study was fewer numbers of 
children and absence of control group. Furthermore, we could 
not evaluate dietary patterns and age of introduction of gluten 
these children. Serum vitamin D levels, other causes of anemia 
like serum B12 and folic acid deficiency were not done in our 
study due to financial constraints. With growing evidence 
of accelerated atherosclerosis in children with CD related to 
hyperhomocysteinemia, vitamin B12 deficiency, vitamin D 
deficiency, deranged lipid profile further studies are suggested in 
future.
CONCLUSION
We conclude that the gastrointestinal manifestations, anemia, 
rickets and short stature still remain common presentations of 
CD in children. Atypical presentation is still uncommon in Indian 
children. Although not significant, serum hemoglobin levels and 
serum iron levels are inversely correlated to the serum tTG levels 
and Marsh biopsy staging (3).
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